MX346273B - Pharmaceutical composition comprising a combination of a non-steroidal anti-inflammatory agent, an adjuvant agent and an antineuritic analgesic, having an antinociceptive effect. - Google Patents

Pharmaceutical composition comprising a combination of a non-steroidal anti-inflammatory agent, an adjuvant agent and an antineuritic analgesic, having an antinociceptive effect.

Info

Publication number
MX346273B
MX346273B MX2012015129A MX2012015129A MX346273B MX 346273 B MX346273 B MX 346273B MX 2012015129 A MX2012015129 A MX 2012015129A MX 2012015129 A MX2012015129 A MX 2012015129A MX 346273 B MX346273 B MX 346273B
Authority
MX
Mexico
Prior art keywords
agent
combination
antineuritic
analgesic
pharmaceutical composition
Prior art date
Application number
MX2012015129A
Other languages
Spanish (es)
Other versions
MX2012015129A (en
Inventor
Larissa Herrera Rodriguez Gisela
Figueroa Nuñez Benigno
Fortino Chavez Carbajal Jose
Eduardo Herrera Abarca Jorge
De Jesus Mateo Villacampa Ramos Jose
Original Assignee
Cecype Services S De R L De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cecype Services S De R L De C V filed Critical Cecype Services S De R L De C V
Priority to MX2012015129A priority Critical patent/MX346273B/en
Priority to ES201590062A priority patent/ES2543364B1/en
Priority to PCT/MX2013/000160 priority patent/WO2014098552A1/en
Publication of MX2012015129A publication Critical patent/MX2012015129A/en
Publication of MX346273B publication Critical patent/MX346273B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the technical field of the pharmaceutical industry and is intended to provide a pharmaceutical composition comprising the synergistic combination of a non-steroidal anti-inflammatory agent, such as the active ingredient meloxicam, an adjuvant agent, such as the active ingredient melatonin and an antineuritic analgesic such as B-complex vitamins (B1, B6 and B12), which are formulated in a single dosage unit that is indicated for the treatment of pain of different etiologies, inflammatory pain, lumbar neuropathy, diabetic neuropathy, trigeminal neuralgia, sciatic neuralgia. The effect of the combination of the aforementioned agents is improved when the agents are administered together in a single dosage unit as opposed to when they are administered independently, generating benefits such as: smaller doses administered, faster therapeutic effect, and fewer side-effects, which can occur when the agents are administered independently.
MX2012015129A 2012-12-19 2012-12-19 Pharmaceutical composition comprising a combination of a non-steroidal anti-inflammatory agent, an adjuvant agent and an antineuritic analgesic, having an antinociceptive effect. MX346273B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MX2012015129A MX346273B (en) 2012-12-19 2012-12-19 Pharmaceutical composition comprising a combination of a non-steroidal anti-inflammatory agent, an adjuvant agent and an antineuritic analgesic, having an antinociceptive effect.
ES201590062A ES2543364B1 (en) 2012-12-19 2013-12-06 PHARMACEUTICAL COMPOSITION UNDERSTANDING THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT, AN ADJUSING AGENT AND AN ANTI-NURETIC ANALGESIC, WITH ANTI-BIOCEPTIVE EFFECT
PCT/MX2013/000160 WO2014098552A1 (en) 2012-12-19 2013-12-06 Pharmaceutical composition comprising a combination of a non-steroidal anti-inflammatory agent, an adjuvant agent and an antineuritic analgesic, having an antinociceptive effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012015129A MX346273B (en) 2012-12-19 2012-12-19 Pharmaceutical composition comprising a combination of a non-steroidal anti-inflammatory agent, an adjuvant agent and an antineuritic analgesic, having an antinociceptive effect.

Publications (2)

Publication Number Publication Date
MX2012015129A MX2012015129A (en) 2014-06-24
MX346273B true MX346273B (en) 2017-02-15

Family

ID=50978771

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012015129A MX346273B (en) 2012-12-19 2012-12-19 Pharmaceutical composition comprising a combination of a non-steroidal anti-inflammatory agent, an adjuvant agent and an antineuritic analgesic, having an antinociceptive effect.

Country Status (3)

Country Link
ES (1) ES2543364B1 (en)
MX (1) MX346273B (en)
WO (1) WO2014098552A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022119429A1 (en) 2020-12-04 2022-06-09 Laboratorios Silanes S.A. De C.V. Fixed combination medicine for the control and management of neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012612A1 (en) * 1995-10-03 1997-04-10 Interneuron Pharmaceuticals, Inc. Compositions of melatonin and analgetic agents and methods of use thereof
CA2556753C (en) * 2004-02-20 2014-11-25 Lifescape Biosciences Incorporated Compositions and methods for sleep regulation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022119429A1 (en) 2020-12-04 2022-06-09 Laboratorios Silanes S.A. De C.V. Fixed combination medicine for the control and management of neuropathic pain

Also Published As

Publication number Publication date
ES2543364A1 (en) 2015-08-18
MX2012015129A (en) 2014-06-24
WO2014098552A1 (en) 2014-06-26
ES2543364B1 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
MX2013011908A (en) Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors.
BR112015027297A8 (en) local and concomitant administration of tolerogenic synthetic nanocarriers to reduce type i and iv hypersensitivity
EA201491285A1 (en) IMPROVED COMPOSITIONS AND METHODS OF DELIVERY OF OMEPRAZOL AND ACETYLSALICYLIC ACID
MX2009008051A (en) Dosage regimen for comt inhibitors.
JP2012193216A5 (en)
MX2014006762A (en) Methods for treating cardiovascular disorder.
PH12014501408A1 (en) Immediate release multi unit pellet system
MX2017013636A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from different particles.
MX2018000546A (en) Pharmaceutical composition containing celecoxib and tramadol.
TN2014000046A1 (en) Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
EA201501164A1 (en) SOLID PHARMACEUTICAL MEDICINE FORM
JO3737B1 (en) THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER
AR101901A1 (en) TREATMENT OF NEURODEGENERATIVE DISEASES WITH A COMBINATION OF LAQUINIMOD AND FINGOLIMOD
MY180772A (en) Novel therapeutic mirtazapine combinations for use in pain disorders
MX2016010892A (en) Agent for improving or preventing progression of chronic kidney disease.
MX2015007280A (en) Combination therapy for cancer.
MX2017013633A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles.
BR112014030288A8 (en) pharmaceutical composition, use thereof, and use of methanesulfonylacetonitrile
MX346273B (en) Pharmaceutical composition comprising a combination of a non-steroidal anti-inflammatory agent, an adjuvant agent and an antineuritic analgesic, having an antinociceptive effect.
MX2013008992A (en) Pharmaceutical composition with anti-inflammatory agents and production process thereof.
MX2018003890A (en) Pharmaceutical compositions containing a muscle relaxant and a non-steroidal anti-inflammatory drug (nsaid).
MX2017013643A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix.
MX2018005298A (en) Dosage regimen for a phosphatidylinositol 3-kinase inhibitor.
BR112012020415A2 (en) pharmaceutical composition for the prevention or treatment of osteoarthritis

Legal Events

Date Code Title Description
FG Grant or registration